DGE’s 3rd Diversity, Equity & Inclusion for Pharma & Healthcare Summit

July 26, 2023 09:35:00

DGE invites life science Diversity, Equity & Inclusion (“DEI”) practitioners, health equity advocates, HR executives, and health policy leaders, to attend the 3rd Advancing Diversity, Equity & Inclusion in Pharma & Healthcare Summit to be held at the Hyatt Bellevue, Philadelphia, PA, on September 19-20, 2023. The industry’s leading event will focus on putting developing policies into practices including novel case studies and sessions on important areas.

The leading DEI event for Pharma & Healthcare serves as a dynamic platform for industry leaders, advocates, practitioners and influencers to convene, work toward common goals and drive the life science ecosystem toward positive change. Attendees will get the unique opportunity to meet with like-minded…

Read More>>

To learn more, please visit https://ibn.fm/S7hSF.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]